文献速递临床微生物分子诊断质量管理与危急值

不同表型方法筛查和检测携带mecC的耐甲氧西林金黄色葡萄球菌的比较

Comparison of Different Phenotypic Approaches To Screen and Detect mecC-Harboring Methicillin-Resistant Staphylococcus aureus.
PubMed 文献 · J Clin Microbiol · 2017-12-26

该研究以111株携带mecC的金黄色葡萄球菌为对象,评估了三种自动化药敏系统、五种选择性显色琼脂平板、头孢西丁纸片扩散法和苯唑西林肉汤微量稀释法检测mecC阳性MRSA的能力。结果显示所有显色平板均能生长,头孢西丁纸片扩散法100%分类为MRSA,而自动化药敏系统存在不同程度的假阴性。

要点

  • 显色琼脂平板能可靠筛查mecC阳性MRSA。
  • 头孢西丁纸片扩散法100%将mecC菌株分类为MRSA。
  • 自动化药敏系统可能将mecC阳性MRSA误判为MSSA,需注意假阴性。

核心结论

  • 头孢西丁是检测mecC阳性MRSA的优越替代标志物。
  • 显色培养基能可靠筛查携带mecC的MRSA。
  • 自动化药敏系统对mecC阳性MRSA存在假阴性结果。

研究设计与样本

  • 采用111株特征明确的mecC阳性金黄色葡萄球菌分离株进行评估。
  • 评估了三种半自动/自动化药敏系统、五种选择性显色琼脂平板、头孢西丁纸片扩散法和苯唑西林肉汤微量稀释法。

主要发现

  • 所有mecC阳性MRSA分离株均能在所有测试的显色MRSA筛查平板上生长。
  • 基于头孢西丁和/或苯唑西林测试的药敏系统总体阳性符合率:MicroScan WalkAway 97.3%,Vitek 2 91.9%,Phoenix 64.9%。
  • 药敏系统最常见的表型耐药模式为「头孢西丁耐药/苯唑西林敏感」,范围从54.1%(Phoenix)和83.8%(Vitek 2)到92.8%(WalkAway)。
  • 头孢西丁纸片扩散法和苯唑西林肉汤微量稀释法分别将100%和61.3%的分离株分类为MRSA。

关键数值与推荐

  • 药敏系统总体阳性符合率:MicroScan WalkAway 97.3%,Vitek 2 91.9%,Phoenix 64.9%。
  • 「头孢西丁耐药/苯唑西林敏感」模式比例:Phoenix 54.1%,Vitek 2 83.8%,WalkAway 92.8%。
  • 头孢西丁纸片扩散法分类为MRSA的比例为100%,苯唑西林肉汤微量稀释法为61.3%。

临床怎么用

  • 筛查mecC阳性MRSA时优先使用显色琼脂平板。
  • 药敏试验中头孢西丁是检测mecC阳性MRSA的优越标志物。
  • 自动化药敏系统报告甲氧西林敏感时需警惕mecC阳性MRSA的假阴性可能。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Similar to mecA, mecC confers resistance against beta-lactams, leading to the phenotype of methicillin-resistant Staphylococcus aureus (MRSA). However, mecC-harboring MRSA strains pose special difficulties in their detection. The aim of this study was to assess and compare different phenotypic systems for screening, identification, and susceptibility testing of mecC-positive MRSA isolates. A well-characterized collection of mecC-positive S. aureus isolates (n = 111) was used for evaluation. Routinely used approaches were studied to determine their suitability to correctly identify mecC-harboring MRSA, including three (semi)automated antimicrobial susceptibility testing (AST) systems and five selective chromogenic agar plates. Additionally, a cefoxitin disk diffusion test and an oxacillin broth microdilution assay were examined. All mecC-harboring MRSA isolates were able to grow on all chromogenic MRSA screening plates tested. Detection of these isolates in AST systems based on cefoxitin and/or oxacillin testing yielded overall positive agreements with the mecC genotype of 97.3% (MicroScan WalkAway; Siemens), 91.9% (Vitek 2; bioMérieux), and 64.9% (Phoenix, BD). The phenotypic resistance pattern most frequently observed by AST devices was "cefoxitin resistance/oxacillin susceptibility," ranging from 54.1% (Phoenix) and 83.8% (Vitek 2) to 92.8% (WalkAway). The cefoxitin disk diffusion and oxacillin broth microdilution assays categorized 100% and 61.3% of isolates to be MRSA, respectively. The chromogenic media tested confirmed their suitability to reliably screen for mecC-harboring MRSA. The AST systems showed false-negative results with varying numbers, misidentifying mecC-harboring MRSA as methicillin-susceptible S. aureus This study underlines cefoxitin's status as the superior surrogate mecC-positive MRSA marker.

来源:J Clin Microbiol,查看原文。版权归原作者所有。

引用

  1. Kriegeskorte A, Idelevich EA, Schlattmann A, et al. Comparison of Different Phenotypic Approaches To Screen and Detect mecC-Harboring Methicillin-Resistant Staphylococcus aureus. J Clin Microbiol. 2017. PMID: 28978682. doi:10.1128/JCM.00826-17

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。